Researchers at Weill Cornell Medicine have shown that three months of social worker follow-up support to people hospitalized with HIV in Tanzania had health benefits at low cost.
A consortium of 13 research institutions, including Cornell, received a $1.5 million grant from The Andrew W. Mellon Foundation to launch the Ivy+ Mellon Leadership Fellows program this fall.
Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by researchers at Weill Cornell Medicine.
Researchers in the Baker Institute for Animal Health have created a genetically engineered mouse model that could shed light on the causes of human infertility and allow researchers to explore other areas of reproduction.
A new study found that patients with non-small cell lung cancer treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy alone.
By teasing out the biological mechanisms in pregnancy-related mental health disorders, investigators at Weill Cornell Medicine are laying the groundwork for new ways to detect and treat pregnant women and new mothers at risk.
The inflammatory response from adaptive immune cells – such as B and T lymphocytes – clears the body of the SARS-CoV-2 virus, but at the same time, it also causes the characteristic symptoms of COVID-19, a new study finds.
A new method could be used by biologists to estimate the prevalence of disease in free-ranging wildlife and help determine how many samples are needed to detect a disease.
Weill Cornell Medicine researchers and Tanzanian colleagues are leveraging clergy's influence to lower life-threatening hypertension rates in Tanzania, and potentially the U.S.